Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Clinical trial NCT03649477 · COMPLETED
Trial details
- NCT number
- NCT03649477
- Sponsor
- Levo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-05-13
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.